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Abstract We examined the ability of peroxynitrite and other
cNO-derived oxidants to inhibit creatine kinase (CK). Peroxyni-
trite potently inhibited CK activity and depleted protein thiols.
The rate constant for this reaction was 8.85U105 M31 s31.
Glutathione did not reactivate CK activity nor did it regenerate
protein thiol content. In contrast, glutathione reactivated CK,
and regenerated protein thiols, after inhibition by either cNO or
oxidized glutathione (GSSG). Peroxynitrite did not irreversibly
inhibit CK after it had been treated with GSSG to block protein
thiols. We conclude that thiol oxidation is a critical event leading
to inactivation of CK by peroxynitrite.
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1. Introduction
Creatine kinase (CK; ATP:creatine N-phosphoryltransfer-
ase, EC 2.7.3.2) catalyzes the reversible transfer of the phos-
phoryl group from phosphocreatine (PCr) to ADP, to form
ATP (Eq. 1). The rate of turnover of the CK reaction exceeds
the rate
PCrADP1CreatineATP 1
of ATP synthesis in the cell by an order of magnitude [1]. This
explains the ability of excitable tissues, such as cardiac, skel-
etal muscle, neurons and retina, to cope with changing energy
consumption rates during periods of increased performance
[2]. Proposed functions of the cellular CK systems include
temporal energy bu¡ering, regulation of oxidative phospho-
rylation and the transport of chemical potential, in the form
of PCr, between sites of ATP production and energy utiliza-
tion [2,3]. Inhibition of myocardial CK compromises contrac-
tile function and end-diastolic pressure at higher workloads
[4^6]. Depression of CK activity in the heart has been impli-
cated in the pathogenesis of cardiomyopathies and heart
failure [7,8].
The active site of CK contains a cysteinyl residue that is
essential for substrate binding. Substitution of this cysteine
with a serine results in a 500-fold decrease in enzyme activity
[9]. Consequently, CK is susceptible to inactivation by oxida-
tive reactions [10,11]. In addition, post-translational modi¢ca-
tion of thiol groups by transnitrosation from S-nitrosothiols
inhibits its catalytic activity [12,13]. Peroxynitrite, formed in
the reaction between superoxide and cNO, is a potent oxidant
of GSH forming GSSG [14], and will oxidize BSA thiols to
unknown products via the formation of a protein thiyl radical
[14,15]. In addition, it oxidizes the Zn ¢nger thiols of alcohol
dehydrogenase with a rate constant of 2.6^5.2U105 M31 s31
[16]. It has been also shown that peroxynitrite is formed in
muscle tissues during sepsis, autoimmune, in£ammatory con-
ditions and ischemia-reperfusion injury [17^21]. In this study,
we investigated the e¡ect of cNO, superoxide and peroxyni-
trite on the activity of CK from muscle tissue. We show that
peroxynitrite is a rapid and irreversible inhibitor of CK activ-
ity. The combination of cNO and superoxide inhibited CK
more potently than either of these agents alone.
2. Materials and methods
2.1. Reagents
Xanthine oxidase (XO), superoxide dismutase (SOD), imidazole,
and CK from rabbit muscle were purchased from Boehringer Mann-
heim (Indianapolis, IN). 1,3-Propanediamine-N-[4-[1-(3-aminopro-
pyl)-2-hydroxy-2-nitrozohydrazino[butyl](spermine NONOate, SNN)
and SIN-1 hydrochloride were obtained from Cayman Chemical
(Ann Arbor, MI). All other reagents were obtained from Sigma (St.
Louis, MO).
2.2. Assay of CK activity
The activity of CK was measured as described by Forster et al.
[22]. ssay medium contained (in mM): imidazole, 100; glucose,
20; MgSO4, 10; ADP, 1; NAD, 0.7; PCr, 35. The reaction was
followed by detecting the formation of NADH at 340 nm after addi-
tion of hexokinase (1 U/ml) and glucose 6-phosphate dehydrogenase
(1 U/ml) [22]. N-Acetylcysteine was omitted from the assay medium to
preserve the status of CK thiol groups. Compounds used to inactivate
CK did not interfere with the activities of hexokinase and glucose
6-phosphate dehydrogenase used in the assay.
2.3. Synthesis of peroxynitrite
Peroxynitrite was prepared as described previously [23]. Brie£y, an
ice cold solution of sodium nitrite (0.6 M) was rapidly mixed with
cold acidi¢ed hydrogen peroxide (0.6 M in 0.8 M HCl) and quenched
with sodium hydroxide (1.4 M). Excess hydrogen peroxide was re-
moved with manganese dioxide. All reactions were performed on
ice. The concentration of peroxynitrite was determined using UV-
visible spectroscopy at V= 302 nm (O= 1670 M31 cm31). The stock
solution of peroxynitrite was diluted in sodium hydroxide (100 mM)
before use.
2.4. Generation of superoxide and cNO
Two systems were employed to simultaneously generate cNO and
superoxide. cNO was formed upon decomposition of SNN in imida-
zole bu¡er (100 mM, pH 6.9). Superoxide radical was generated in a
system containing xanthine (10 WM) and XO (2 mU/ml). SIN-1, a
sydnonimine, spontaneously decays in aerobic bu¡er to generate
both nitric oxide and superoxide [24] and has been used as a model
for the continuous formation of peroxynitrite [25]. SIN-1 was decom-
posed to peroxynitrite in aerobic imidazole bu¡er (100 mM, pH 6.9).
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2.5. Chromatographic separation of CK
After incubation with inhibitors or GSH, CK was reisolated in
imidazole bu¡er (100 mM, pH 6.9) on a Sephadex G-25 column. After
separation protein was concentrated using Centricon-50 ultra¢ltration
devices (Millipore, Bedford, MA).
2.6. Assays of protein thiols and protein concentration
Protein thiols were measured using 5,5P-dithiobis-(2-nitrobenzoic
acid) (DTNB) at V= 412 nm (O= 11 000 M31 cm31). Protein was de-
termined using the Bradford assay [26].
3. Results
3.1. E¡ect of peroxynitrite on CK activity
As shown in Fig. 1A, peroxynitrite caused a concentration
dependent inhibition of CK (4 Wg/ml or 48 nM) activity with
an IC50 (concentration required to inhibit 50% of enzyme
activity) of 2.5 WM. At this concentration of peroxynitrite
and CK, approximately 50 mol of peroxynitrite are required
to inactivate 1 mol of enzyme. Decomposed peroxynitrite (i.e.
allowed to decompose in imidazole bu¡er, 100 mM, pH 6.9
for 10 min) did not inhibit CK activity (not shown). A kinetic
analysis of the data shown in Fig. 1A was performed using the
approach taken by Padmaja et al. [27]. If it is assumed that a
1:1 stoichiometric ratio exists between peroxynitrite and en-
zyme
CKActive ONOO3ÿ!k1 CKInactive  Products 2
ONOO3ÿ!k2 Products 3
ONOO3  ZA03Ai  k2k1
 
ln
A0
Ai
 
4
inactivation (Eq. 2), and that the only other route of perox-
ynitrite decomposition is spontaneous decay (Eq. 3), then
competition analysis gives Eq. 4, where A0 is enzyme activity
before addition of peroxynitrite, AI is enzyme activity after
peroxynitrite, Z is a factor to convert enzyme activity to con-
centration of active enzyme. The value of k2 is 2.84 s31 at pH
6.9 (calculated from k2 = 0.9 s31 at pH 7.4 and pK = 6.8 for
peroxynitrite). Fig. 1A shows a ¢t of Eq. 4 to the experimental
data giving k1 = (8.85 þ 1.10)U105 M31 s31 and Z = 6.9 nM.
The inhibitory activity of peroxynitrite was not dependent on
the bu¡er system as the irreversible inhibition of CK was also
observed using phosphate bu¡er (100 mM, pH 6.9, containing
100 WM DTPA).
Incubation of CK in bu¡er containing the cNO donor, SNN
(1 WM) or components of the superoxide generating system
(10 WM xanthine + 2 mU/ml XO) caused little inactivation of
CK (Fig. 1B). However, in combination, these agents caused a
time dependent inhibition of enzyme activity, leading to com-
plete inactivation within 20 min (Fig. 1B).
SIN-1, in the presence of oxygen, decomposes to form equal
amounts of cNO and superoxide which combine to form per-
oxynitrite [24,25]. SIN-1 (100 WM) completely inhibited en-
zyme activity after 20 min (Fig. 2A). In the presence of bicar-
bonate (1 and 25 mM), the inhibition of CK was slightly
enhanced (Fig. 2A). The decomposition product of SIN-1,
SIN-1C, had no e¡ect on CK activity (Fig. 2A). SOD was
used to scavenge superoxide and thus prevent the formation
of peroxynitrite during SIN-1 decomposition. SOD protected
CK from SIN-1-dependent inhibition in a concentration de-
pendent manner (Fig. 2B). This protection was speci¢c for
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Fig. 1. E¡ect of peroxynitrite on CK activity. A: Peroxynitrite
(0^10 WM in 100 mM NaOH) was added to CK (4 Wg/ml in
100 mM imidazole, pH 6.9, containing 100 WM DTPA) and vortex-
mixed immediately. The pH of the mixture was not signi¢cantly al-
tered by addition of peroxynitrite. CK activity (b) was determined
within 10 min. The solid line represents a ¢t of Eq. 4 to the data
where k1 = (8.85 þ 1.1)U105 M31 s31. B: CK (4 Wg/ml) in 100 mM
imidazole, pH 6.9, containing 100 WM DTPA) was incubated with
SNN (1 WM) (b), XO (2 mU/ml) and xanthine (10 WM) (R), or a
combination of all three agents (F), for 20 min. Aliquots were re-
moved at the indicated times and assayed for CK activity. Data
represent mean þ S.E.M. (n = 3).
Fig. 2. E¡ect of SIN-1 on CK activity. A: E¡ect of SIN-1 and
SIN-1C on CK activity. CK was incubated in 100 mM imidazole
bu¡er (pH 6.9) containing 100 WM DTPA at 37‡C with 100 WM
SIN-1 or with the product of SIN-1 decomposition, SIN-1C;
(a, SIN-1C; b, SIN-1; R, SIN-1 in the presence of 1 mM of
NaHCO3 ; F, SIN-1 in the presence of 25 mM NaHCO3). B: E¡ect
of SOD on SIN-1 induced inhibition of CK activity. CK was incu-
bated with SIN-1 (100 WM) and the indicated concentrations of
SOD (a) or BSA (b) for 30 min at 37‡C in imidazole bu¡er
(100 mM, pH 6.9) containing 100 WM DTPA. SOD activity was
5000 U/mg protein. Data represent mean þ S.E.M. (n = 3).
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SOD, as bovine serum albumin (BSA) did not a¡ect SIN-1-
induced inhibition of CK.
3.2. Recovery of CK activity and protein thiols
Reduced glutathione (GSH) is a predominant cellular thiol
present in cytosol at high concentrations (1^10 mM) that acts
to maintain intracellular thiols in a reduced state. It follows
that any inhibition of enzyme activity that occurs as a result
of thiol oxidation may be subject to repair by GSH. We
examined if GSH was able to reactivate CK after inactivation
by the simultaneous generation of cNO and superoxide. CK,
inactivated to 0.8% of initial activity, was incubated for 30
min with 10 mM GSH. After this treatment, enzyme activity
was recovered to only 5% of its initial value (not shown).
Thus, the inactivation of CK, from the simultaneous genera-
tion of cNO and superoxide could not be reversed by GSH.
Similar results were obtained using dithiothreitol as a thiol
reducing agent (not shown).
CK previously inactivated by SIN-1, was incubated with
GSH (10 mM) for 30 min. GSH treatment recovered CK
activity to only 20% of the initial value (Fig. 3A). In contrast,
the activity of CK inhibited with SNN was completely recov-
ered upon addition of 10 mM GSH (Fig. 3A). SIN-1 dramat-
ically decreased the amount of DTNB detectable thiol groups
(Fig. 3B). After addition of 10 mM GSH, only 20% of thiols
were regenerated indicating that SIN-1 chemically modi¢es
CK thiols predominantly to a form that is not reducible by
GSH. SNN also reduced the amount of thiols, however, ad-
dition of GSH completely regenerated protein thiols to initial
values (Fig. 3B).
Peroxynitrite is a fairly non-speci¢c oxidant and several
other amino acid residues, such as tyrosine and methionine,
can be modi¢ed by reaction with peroxynitrite. In order to
determine if protein thiol modi¢cation is the mechanism for
CK inactivation, CK thiol groups were shielded by reversible
thiolation with oxidized glutathione (GSSG). Incubation of
CK with GSSG decreased both CK activity and the protein
associated thiol concentration (Table 1). This preparation of
CK was exposed to SIN-1 (10 mM for 60 min), after which it
was incubated with GSH (10 mM for 60 min). GSH regen-
erated thiols after SIN-1 treatment and enzyme activity was
completely recovered (Table 1). This result indicates that the
oxidation of protein thiols is the major mechanisms of SIN-1
dependent enzyme inactivation and that additional modi¢ca-
tion of other amino acid residues does not a¡ect the activity
of CK.
4. Discussion
The study shows that CK is extremely sensitive to both
authentic peroxynitrite and the simultaneous generation of
cNO and superoxide. The rate constant for the reaction be-
tween peroxynitrite and the active-site thiol of CK was deter-
mined to be (8.85 þ 1.1)U105 M31 s31. This rate constant is
similar to that determined for heme-containing peroxidases of
3.3^64U105 M31 s31 [28] and for the Zn ¢nger thiols of
alcohol dehydrogenase (2.6^5.2U105 M31 s31) [16]. Interest-
ingly, the rate constant is signi¢cantly larger than that for the
selenol-containing glutathione peroxidase (4.5U104 M31 s31)
[27] and for the thiol group of bovine serum albumin (2.6^
2.8U103 M31 s31) [14]. Peroxynitrite is a substantially more
potent agent than either superoxide, cNO (Fig. 1B), or hydro-
gen peroxide (unpublished observations).
Peroxynitrite is able to oxidize thiol groups [14,15], and to
nitrate tyrosine residues [29]. The active site of CK contains
an essential cysteine residue [9], and the MgADP binding site
contains tyrosine residues [30]. These could be the targets for
peroxynitrite and modi¢cation/oxidation of these residues
may be responsible for enzyme inhibition. This study suggests
that peroxynitrite induced CK inhibition is due to the oxida-
tion of protein thiol groups. CK activity correlates well with
DTNB detectable thiol concentration, and it has previously
been established that only the active site cysteine of CK can
be detected in non-denaturing conditions [31]. Inhibition of
CK activity by peroxynitrite and SNN is associated with a
decreased amount of protein thiols, and the degree of the
enzyme reactivation by GSH is paralleled by the regeneration
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Table 1
E¡ect of GSH on protein thiols and activity of CK exposed to SIN-1, after shielding protein thiol groups with GSSG
Activity (U/mg protein) Protein thiols (nmol/mg protein)
CK 142 þ 8 18.2 þ 0.5
CK+GSSG 23 þ 0.8 2.0 þ 0.6
CK+GSSG+SIN-1 6 þ 0.4 1.3 þ 0.2
CK+GSSG+SIN-1+GSH 135 þ 5 14.5 þ 0.2
CK was incubated with 5 mM GSSG for 60 min in imidazole bu¡er (100 mM, pH 6.9 containing 100 WM DTPA). After separation, CK was treated
with SIN-1 (10 mM) for 60 min. Isolated protein was reactivated with GSH (10 mM) for 60 min. Data represent mean þ S.E.M. (n=3).
Fig. 3. E¡ect of GSH on protein thiols and activity of CK inhibited
with peroxynitrite donor SIN-1 or cNO donor SNN. CK was incu-
bated at room temperature for 30 min with SIN-1 (10 mM) or for
120 min with SNN (10 mM) in imidazole (100 mM) bu¡er contain-
ing 100 WM DTPA. After incubation CK was separated from SIN-1
and incubated with 10 mM GSH, and then concentrated and sepa-
rated from GSH for protein thiols and activity assays. Control,
white bar; after SIN-1 treatment, black bar; after SIN-1 followed
by GSH treatment, hatched bar. Data represent mean þ S.E.M.
(n = 3).
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of thiol groups (Fig. 3). In addition, SIN-1 did not cause
irreversible inhibition of CK when the enzyme thiol groups
had been shielded by reversible thiolation with GSSG (Table
1).
CK previously inactivated with peroxynitrite could not be
reactivated by thiol reducing agents nor could the active site
thiol be repaired. This suggests that neither S-nitrosation nor
sulfenic acid formation is the mechanism of enzyme inactiva-
tion. The nitrosating agent, S-nitrosoglutathione (GSNO), is
also known to potently inhibit CK, but its inhibitory e¡ect is
reversed by the excess of GSH [12,13] (unpublished results).
High concentrations of cNO also inactivate the enzyme (Fig.
3), but, as in the case of GSNO, the inhibition was completely
reversed by GSH. These results implicate peroxynitrite as the
most likely and potent oxidant to cause irreversible inactiva-
tion of CK in vivo. Peroxynitrite is known to combine rapidly
with carbon dioxide, present at relatively high concentrations
inside the cells, to form ONOOCO32 [32]. Therefore it is im-
portant to examine the e¡ect of bicarbonate on peroxynitrite
dependent reactions. Inactivation of CK by SIN-1, in the
presence of bicarbonate was slightly accelerated. Interestingly,
bicarbonate has been demonstrated to inhibit peroxynitrite
dependent thiol oxidation [32] and partially to inhibit the in-
activation of glutathione peroxidase [27]. This suggests that
the active site of CK does not behave like a low molecular
weight thiol and that neighboring residues appear to in£uence
the reactivity of peroxynitrite with the active site thiol. The
in£uence of close neighbor residues on peroxynitrite chemistry
has previously been demonstrated, as peroxynitrite dependent
tyrosine nitration is facilitated by the presence of glutamate
[33].
Exogenous peroxynitrite has been reported to impair car-
diac contractile function without reduction in energy substrate
utilization and oxygen consumption [34]. The decreased car-
diac e⁄ciency is likely to be due to uncoupling between pro-
duction of ATP and its utilization by myo¢brils. This could be
due to the inhibition of CK, which provides the coupling
between the energy producing and energy utilizing processes
within the cell. Inhibition of myocardial CK in isolated rat
heart results in reduced contractile reserve indicating that CK
ensures mechanical function during periods of increased per-
formance [5,6]. Peroxynitrite formation in cardiac tissue as a
result of pathological processes may consequently lead to im-
paired contractile function. For example, the reduced myocar-
dial contractility and deteriorated hemodynamics associated
with experimental autoimmune myocarditis, which is im-
proved by iNOS inhibitors, may be due to the formation of
peroxynitrite [35,36].
In conclusion, the present data indicate that peroxynitrite is
a rapid and irreversible inactivator of CK. In contrast, cNO
and superoxide alone are much less potent inhibitors of CK
and their e¡ects can be reversed by GSH.
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